Literature DB >> 7743712

Reconstruction of midfacial defects after surgical resection of malignancies.

M D Wells1, E A Luce.   

Abstract

Midfacial and orbital defects after ablative oncologic surgery are difficult problems for the reconstructive surgeon. Our goal is to address the devastating functional and aesthetic consequences of these extirpations and to improve the quality of life for this unfortunate group of patients. Partial maxillectomy defects are best treated by skin grafting the residual cavity and reconstructing the maxillary defect by prosthetic means. Local tissues can be used when the defects are small and the bone loss is not extensive. For massive midfacial defects with insufficient bony support for prosthetic reconstruction, osseocutaneous free flaps have proved useful to restore contour and the necessary structural support.

Entities:  

Mesh:

Year:  1995        PMID: 7743712

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  5 in total

1.  Midface reconstruction.

Authors:  Omer Ozkan; O Koray Coşkunfirat; Ozlenen Ozkan
Journal:  Semin Plast Surg       Date:  2010-05       Impact factor: 2.314

Review 2.  Palatomaxillary Reconstruction: Fibula or Scapula.

Authors:  Arvind K Badhey; Mohemmed N Khan
Journal:  Semin Plast Surg       Date:  2020-05-06       Impact factor: 2.314

3.  Microsurgical reconstruction of large, locally advanced cutaneous malignancy of the head and neck.

Authors:  Joseph L Hill; Brian Rinker
Journal:  Int J Surg Oncol       Date:  2011-10-20

4.  Quality of life and problems associated with obturators of patients with maxillectomies.

Authors:  Marwa Mohammed Ali; Nadia Khalifa; Mohammed Nasser Alhajj
Journal:  Head Face Med       Date:  2018-01-05       Impact factor: 2.151

5.  Repair of Orbital Post-Traumatic Wall Defects by Custom-Made TiNi Mesh Endografts.

Authors:  Valentin Shtin; Valeriy Novikov; Timofey Chekalkin; Victor Gunther; Ekaterina Marchenko; Evgeniy Choynzonov; Seung Baik Kang; Moon Jong Chang; Ji Hoon Kang; Aleksei Obrosov
Journal:  J Funct Biomater       Date:  2019-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.